Valued at $1.5B at a merger or acquisition, Dec 2025. Nothing has traded since.
- ·The complete investor list: 16 names
- ·Watch Arthrosi Therapeutics: the Monday email on marks, rounds and moves
Valuation timeline
0 priced rounds · 32 daily marks since · Sep 2026 – Oct 2026Membership and data by Private Market View
Arthrosi Therapeutics funding history
7 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Jun 2025 | Later Stage VC | $60.9M | ▮ | ▮ |
| Sep 2023 | Early Stage VC | $7.0M | ▮ | ▮ |
| Feb 2023 | Early Stage VC | $15.0M | ▮ | ▮ |
| Aug 2021 | Early Stage VC | $26.0M | ▮ | ▮ |
| May 2020 | Early Stage VC | $8.5M | ▮ | ▮ |
| Oct 2018 | Early Stage VC | $11.0M | ▮ | ▮ |
| + 1 earlier rounds · a free account shows the full history | ||||
Membership and data by Private Market View
Arthrosi Therapeutics valuation
Arthrosi Therapeutics was valued at $1.5 billion at a merger or acquisition in Dec 2025. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.
How much has Arthrosi Therapeutics raised?
Arthrosi Therapeutics has raised $299 million in total; 7 of its rounds are on record, from 2018 on. The largest on record was an $8.5 million early-stage round in May 2020; the most recent was a $60.9 million later-stage round in Jun 2025.
Arthrosi Therapeutics has filed 8 Form Ds with the SEC since 2018, most recently in Jun 2025 ($60.9 million sold to 13 investors).
How Arthrosi Therapeutics's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For Arthrosi Therapeutics, the most current credible signal sets the number and the older ones confirm it: a live secondary-market price first, then three or more recent prints, then institutional fund marks, and otherwise the last priced round, which never decays. The valuation is the last round’s post-money moved by the price change since that round, so no share count is assumed. Today it is set by its last priced round. Question about this number? Full methodology →
Frequently asked about Arthrosi Therapeutics
- What is Arthrosi Therapeutics worth?
- Arthrosi Therapeutics is valued at $1.5B as of Oct 2026. Valued at $1.5B at a merger or acquisition, Dec 2025. Nothing has traded since.
- How much has Arthrosi Therapeutics raised?
- Arthrosi Therapeutics has raised $298.8M in total funding across 7 recorded rounds.
- When did Arthrosi Therapeutics last raise?
- Arthrosi Therapeutics last raised in Jun 2025 (Later Stage VC), raising $60.9M.